Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box P3 (FOXP3) is a transcription factor that serves as the master regulator for the development and inhibitory function of regulatory T cells (Tregs) [UniProt, Hori et al., 2003]. It belongs to the forkhead/winged-helix family and is primarily expressed in a subset of CD4+ T cells, where it controls the expression of genes essential for immune suppression, such as IL-10 and CTLA-4 [NCBI Gene, Togashi et al., 2019]. FOXP3 is critical for maintaining peripheral tolerance; its deficiency or mutation leads to the development of IPEX syndrome, a severe multi-organ autoimmune disease [StatPearls]. In oncology, FOXP3+ Tregs are often recruited to the tumor microenvironment, where they facilitate immune evasion by inhibiting the activity of cytotoxic T cells and natural killer cells [Togashi et al., 2019]. Consequently, FOXP3 and the cells expressing it are major targets for therapeutic intervention, with strategies focusing on depleting Tregs in cancer or expanding/stabilizing them in autoimmune and inflammatory conditions [Hori et al., 2003; Togashi et al., 2019; Klatzmann & Abbas, 2015].
Modulation of regulatory T cell (Treg) development and suppressive function through transcriptional regulation of immune-related genes, or direct depletion/expansion of FOXP3-expressing cell populations [Hori et al., 2003; Togashi et al., 2019; Klatzmann & Abbas, 2015].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box P3 (FOXP3).